Malaysia
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
71.11%
|
March 31, 2024 | USD 3.29 | -0.45% |
|
Malaysia |
|
2 |
24.93%
|
June 30, 2024 | USD 0.94 | -2.12% |
|
Malaysia |
|
3 |
9.78%
|
Dec. 31, 2023 | USD 0.51 | -1.32% |
|
Malaysia |
|
4 |
8.98%
|
Dec. 31, 2023 | USD 0.27 | -1.64% |
|
Malaysia |
|
5 |
5.53%
|
May 31, 2024 | USD 0.22 | -0.04% |
|
Malaysia |
|
6 |
2.09%
|
March 31, 2024 | USD 0.80 | -0.04% |
|
Malaysia |
|
7 |
-1.25%
|
Aug. 31, 2024 | USD 0.27 | -0.87% |
|
Malaysia |
|
8 |
-27.23%
|
June 30, 2024 | USD 0.25 | -1.78% |
|
Malaysia |
|
9 |
-147.19%
|
Dec. 31, 2023 | USD 1.35 | -31.47% |
|
Malaysia |
The Pharmaceuticals company in Malaysia with the highest EBT Margin is Ajinomoto (Malaysia) Bhd (Kuala Lumpur Stock Exchange: 2658.KL) at 71.11%.
The Pharmaceuticals company in Malaysia with the lowest EBT Margin is Agape ATP Corporation (NasdaqCM: ATPC) at -147.19%.
The top 10 Pharmaceuticals companies in Malaysia by EBT Margin are Ajinomoto (Malaysia) Bhd, Kotra Industries Berhad, KPJ Healthcare Berhad, Duopharma Biotech Berhad, Ancom Nylex Berhad, Hartalega Holdings Berhad, Top Glove Corporation Bhd., Supermax Corporation Berhad and Agape ATP Corporation.
The bottom 10 Pharmaceuticals companies in Malaysia by EBT Margin are Agape ATP Corporation, Supermax Corporation Berhad, Top Glove Corporation Bhd., Hartalega Holdings Berhad, Ancom Nylex Berhad, Duopharma Biotech Berhad, KPJ Healthcare Berhad, Kotra Industries Berhad and Ajinomoto (Malaysia) Bhd.